US EditionGPs can prescribe weight loss jabs on the NHS from today - but strict eligibility criteria in place
- On Monday, June 23, 2025, GPs in England began prescribing weight loss injections on the NHS for the first time, launching a mass rollout across the country.
- This rollout responds to rising obesity rates, with about 29% of UK adults classified as obese and prior access to these drugs limited to specialists or private prescriptions.
- Eligibility initially requires a BMI over 40 plus four additional obesity-related health conditions, while the treatment includes lifestyle coaching alongside medication.
- Approximately 220,000 people with the greatest need are expected to receive Mounjaro over the next three years, though concerns about GP workloads and drug supply strains remain.
- The programme aims to improve obesity management and reduce NHS costs, but experts stress ongoing evaluation and that these drugs are not a standalone solution.
33 Articles
33 Articles
Mounjaro becomes available on the NHS: what to know and what to do if you’re not eligible
bigshot01/ShutterstockObesity remains one of the most pressing, and preventable, health challenges of our time. The UK is one of a number of countries undoubtedly struggling with it. It affects nearly every organ system in the body, contributing to cardiovascular conditions like coronary heart disease; musculoskeletal issues such as osteoarthritis and gout; and even the development of certain cancers, including of the breast, uterus and colon. I…
Mounjaro: Britons warned of 'very common' side effects as weight loss drug sees mass NHS rollout - including nausea & vomiting
In a major milestone for slimmers, the NHS has begun its mass rollout of the weight-loss drug Mounjaro, with GPs able to prescribe the medication for the first time
As of Monday, June 23, these treatments that have revolutionized the management of the disease can be prescribed by general practitioners. Who are they addressing, are they effective, what side effects? "Libé" takes stock.
Who can access the new Mounjaro weight loss jab on the NHS?
The NHS has begun a mass rollout of weight loss jabs in England, with GPs allowed to prescribe the medicine for the first time.Over the next 12 years through NHS primary care providers, 1.6 million people are expected to receive tirzepatide, a weight loss drug sold under the brand name Mounjaro.The drug was initially produced and licensed for type 2 diabetes by American pharmaceutical giant Eli Lilly. The drug reduced the appetite for patients m…
'King Kong' of weight loss jabs Mounjaro available on NHS to those in need from TODAY - The Mirror
Around 220,000 people with "greatest need" are expected to receive Mounjaro, also known as tirzepatide and made by Lilly through the NHS over the next three years
Coverage Details
Bias Distribution
- 59% of the sources are Center
To view factuality data please Upgrade to Premium
